1: Konno M, Asai A, Kawamoto K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review). Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3885. [Epub ahead of print] doi: 10.1016/j.chemosphere.2017.02.066. [Epub ahead of print] doi: 10.1016/j.jchromb.2017.02.018. [Epub ahead of print] doi: 10.1016/j.bpj.2016.12.027. doi: 10.1155/2017/1646140. 10: Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, Ståhlman M, Adiels M, Hakkarainen A, Lundbom N, Kilicarslan M, Hallström BM, Lundbom J, Vergès B, Barrett PH, Watts GF, Serlie MJ, Nielsen J, Uhlén M, Smith U, Marschall HU, Taskinen MR, Boren J. Personal model-assisted identification of NAD(+) and glutathione metabolism as intervention target in NAFLD. Mol Syst Biol. 2017 Mar 2;13(3):916. doi: 10.15252/msb.20167422. doi: 10.1186/s12870-017-1006-6. doi: 10.1371/journal.pone.0173078. doi: 10.1021/acsmacrolett.7b00015. 16: Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, Scheppke L, Bonelli R, Yannuzzi LA, Friedlander M; MacTel Project Consortium., Egan CA, Fruttiger M, Leppert M, Allikmets R, Bahlo M. Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet. 2017 Feb 27. doi: 10.1038/ng.3799. [Epub ahead of print] doi: 10.1063/1.4976646. doi: 10.1159/000450908. doi: 10.1159/000454853. doi: 10.1016/j.molimm.2017.02.010. [Epub ahead of print]